Cargando…

Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein

Tetra-arsenic tetra-sulfide (As(4)S(4)) is an arsenic compound with anti-tumor activity, especially in acute promyelocytic leukemia (APL) that are resistant to retinoic acid (RA). Although recent studies revealed that the therapeutic action of As(4)S(4) is closely associated with the induction of ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yuwang, Liu, Yanfeng, He, Pengcheng, Liu, Feng, Zhou, Naicen, Cheng, Xiaoyan, Shi, Lili, Zhu, Huachao, Zhao, Jing, Wang, Yuan, Zhang, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890287/ https://www.ncbi.nlm.nih.gov/pubmed/24454695 http://dx.doi.org/10.1371/journal.pone.0083184

Ejemplares similares

Expression of Concern: Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein
Publicado: (2014)

Role of cofilin-1 in arsenic trioxide-induced apoptosis of NB4-R1 cells
por: Zhu, Huachao, et al.
Publicado: (2020)

Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4
por: Rossi, Annalisa, et al.
Publicado: (2010)

Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia
por: Lallemand-Breitenbach, Valérie, et al.
Publicado: (1999)

Specific Uptake of Retinoids into Human Promyelocytic Leukemia Cells HL‐60 by Retinoid‐specific Binding Protein: Possibly the True Retinoid Receptor
por: Hashimoto, Yuichi, et al.
Publicado: (1988)

Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia
por: Zhang, Li, et al.
Publicado: (2021)

PB1901: NOT ALL VARIANTS OF ACUTE PROMYELOCYTIC LEUKEMIAS ARE RESISTANT TO RETINOIDS.
por: Dandwani, Mehndi, et al.
Publicado: (2023)

pH homeostasis in promyelocytic leukemic HL60 cells
Publicado: (1988)

Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis
por: Pan, Chaoyun, et al.
Publicado: (2016)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals
por: Fan, Xiao-Yang, et al.
Publicado: (2016)

cFos Mediates cAMP-Dependent Generation of ROS and Rescue of Maturation Program in Retinoid-Resistant Acute Promyelocytic Leukemia Cell Line NB4-LR1
por: Carrier, Jean-Luc, et al.
Publicado: (2012)

TAF-Iβ deficiency inhibits proliferation and promotes apoptosis by rescuing PP2A and inhibiting the AKT/GSK-3β pathway in leukemic cells
por: Liu, Yanfeng, et al.
Publicado: (2019)

Speciation of arsenic in sulfidic waters
por: Wilkin, Richard T, et al.
Publicado: (2003)

Retinoid Induces the Degradation of Corneodesmosomes and Downregulation of Corneodesmosomal Cadherins: Implications on the Mechanism of Retinoid-induced Desquamation
por: Kim, Moon Young, et al.
Publicado: (2011)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Biphenotypic Acute Leukemia with t(15;17) Lacking Promyelocytic-retinoid Acid Receptor α Rearrangement
por: Saito, Makoto, et al.
Publicado: (2013)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells
por: Wang, Shuping, et al.
Publicado: (2015)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Regulation of acid phosphatase activity in human promyelocytic leukemic cells induced to differentiate in culture
Publicado: (1979)

Arsenic sulfide as a potential anti-cancer drug
por: DING, WENPING, et al.
Publicado: (2015)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells
por: Zhang, Tao, et al.
Publicado: (2015)

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022)

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
por: Tinajero, Jose, et al.
Publicado: (2022)

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies
por: Hirano, Seishiro, et al.
Publicado: (2022)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

High Infrared Photoconductivity in Films of Arsenic-Sulfide-Encapsulated Lead-Sulfide Nanocrystals
por: Yakunin, Sergii, et al.
Publicado: (2014)

Hydrothermal Treatment of Arsenic Sulfide Residues from Arsenic-Bearing Acid Wastewater
por: Yao, Liwei, et al.
Publicado: (2018)

Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
por: Li, Tao, et al.
Publicado: (2018)

Tanshinone IIa Induces Autophagy and Apoptosis via PI3K/Akt/mTOR Axis in Acute Promyelocytic Leukemia NB4 Cells
por: Pan, Yiming, et al.
Publicado: (2021)

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia
por: Liu, Xiao, et al.
Publicado: (2023)

Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry
por: Ceni-Silva, Vitória, et al.
Publicado: (2021)

Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia
por: Wang, Fei-Fei, et al.
Publicado: (2016)

Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line
por: Baek, Jin Ho, et al.
Publicado: (2012)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s4s1vdd102rcutdpuffro79r5c